GRDN
Guardian Pharmacy Services, Inc.
NYSE · Healthcare · Medical - Distribution · US
$40.45
+0.30%Year over year
Reported trailing growth
- Revenue
- +10.3%
- EBITDA
- +392.0%
- EBIT
- +247.3%
- EPS
- +170.0%
- Free cash flow
- +110.4%
- Operating cash flow
- +71.4%
Forward estimates
Based on analyst estimates
- Revenue
- +3.3%
- EBITDA
- +22.8%
- EPS
- +32.5%
Three-year CAGR
- Revenue
- +16.8%
- EBITDA
- +12.3%
- EBIT
- +19.6%
- Net income
- +11.6%
- EPS
- +10.8%
- Free cash flow
- +36.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026